Gene · 1108
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine. | EMBO Mol Med | 2023 | 37675835 | PubTator, text mining | PubMed |
| Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics. | Genome Biol | 2023 | 37674236 | PubTator, text mining | PubMed |
| JARID2 coordinates with the NuRD complex to facilitate breast tumorigenesis through response to adipocyte-derived leptin. | Cancer Commun (Lond) | 2023 | 37658635 | PubTator, text mining | PubMed |
| SAP30 promotes breast tumor progression by bridging the transcriptional corepressor SIN3 complex and MLL1. | J Clin Invest | 2023 | 37655663 | PubTator, text mining | PubMed |
| The Role of Myositis-Specific and Myositis-Associated Autoantibodies and the Activation of Type I Interferon Pathway in the Generation of Clinical Phenotypes of Inflammatory Myopathies. | Mediterr J Rheumatol | 2023 | 37654645 | PubTator, text mining | PubMed |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. | Front Oncol | 2023 | 37637064 | PubTator, text mining | PubMed |
| Human Exome Sequencing and Prospects for Predictive Medicine: Analysis of International Data and Own Experience. | J Pers Med | 2023 | 37623486 | PubTator, text mining | PubMed |
| The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. | NAR Cancer | 2023 | 37609662 | PubTator, text mining | PubMed |
| Wnt3a signaling with serum supply induces replication stress in cultured cells. | Biochem Biophys Rep | 2023 | 37601449 | PubTator, text mining | PubMed |
| Dysregulated Signalling Pathways Driving Anticancer Drug Resistance. | Int J Mol Sci | 2023 | 37569598 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection perturbs enhancer mediated transcriptional regulation of key pathways. | PLoS Comput Biol | 2023 | 37561814 | PubTator, text mining | PubMed |
| NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice. | BMC Res Notes | 2023 | 37550734 | PubTator, text mining | PubMed |
| Exosome miRNAs profiling in serum and prognostic evaluation in patients with multiple myeloma. | Blood Sci | 2023 | 37546707 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis. | BMC Med Genomics | 2023 | 37525242 | PubTator, text mining | PubMed |
| An Unusual Presentation of Dermatomyositis With Muscle Hypertrophy. | Cureus | 2023 | 37519595 | PubTator, text mining | PubMed |
| Hepatitis Delta Virus-Host Protein Interactions: From Entry to Egress. | Viruses | 2023 | 37515216 | PubTator, text mining | PubMed |
| CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions. | Int J Mol Sci | 2023 | 37511548 | PubTator, text mining | PubMed |
| Transposable Elements: Epigenetic Silencing Mechanisms or Modulating Tools for Vertebrate Adaptations? Two Sides of the Same Coin. | Int J Mol Sci | 2023 | 37511347 | PubTator, text mining | PubMed |
| Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer-Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects. | Int J Mol Sci | 2023 | 37511115 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1108/papers?page=11